The Relationship Between TNF‐α Inhibitor Potency and HBV Reactivation in Patients With Rheumatic Disorders
High-potency TNF-α inhibitors significantly increase HBV reactivation risk in HBsAg+ patients, while HBsAg-/HBcAb+ patients have a uniformly low risk across all inhibitors.
Authors
- Ning‐Sheng Lai (ORCID: https://orcid.org/0000-0001-6853-7451)
- Kuang‐Yung Huang (ORCID: https://orcid.org/0000-0001-8399-6226)
- Chien‐Hsueh Tung (ORCID: https://orcid.org/0000-0003-1234-6263)
- Kuo‐Chih Tseng (ORCID: https://orcid.org/0000-0002-4811-3018)
- Chih‐Wei Tseng (ORCID: https://orcid.org/0000-0002-6951-4646)
- N Chen
- Meng‐Hsuan Kuo (ORCID: https://orcid.org/0000-0003-3124-3104)
- Ming‐Chi Lu (ORCID: https://orcid.org/0000-0001-9051-0351)
Institutions
- Tzu Chi University (TW)
- Taipei Tzu Chi Hospital (TW)
Publication Details
- Journal
- Liver International
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1111/liv.70152
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71